Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis
Cogent Biosciences, Inc.
Cogent Biosciences, Inc.
Karyopharm Therapeutics Inc
Orca Biosystems, Inc.
Novartis
Duke University
Novartis
Novartis
Sellas Life Sciences Group
Novartis
AbbVie
Novartis
University of California, San Francisco
Takeda
Barbara Ann Karmanos Cancer Institute
Novartis
Novartis